ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,846.80
0.55%
US Tech 100
19,904.40
0.86%
Dow Jones
42,912.14
0.11%
Brent Oil
77.565
0.13%
Bitcoin
65,917.51
4.88%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Conduit Pharmaceuticals Inc (CDT) Quote

Conduit Pharmaceuticals Inc

Conduit Pharmaceuticals Inc (CDT)

Castle Minerals Limited
0.1066
-0.0098
( -8.42% )
Updated: 10:45:27
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.1066
Bid
0.1065
Ask
0.1081
Volume
6,302,158
0.1027 Day's Range 0.1108
0.095 52 Week Range 7.7509
Market Cap
10.234M
Previous Close
0.1164
Open
0.11
Last Trade
230
@
0.1066
Last Trade Time
10:45:27
Financial Volume
$ 673,583
VWAP
0.106881
Average Volume (3m)
17,244,002
Shares Outstanding
96,004,699
Dividend Yield
-
PE Ratio
-267.04
Earnings Per Share (EPS)
-0.06
Revenue
-
Net Profit
-6.06M

About Conduit Pharmaceuticals Inc

Conduit Pharmaceuticals, Inc. is a disease agnostic life science company. The Company is engaged in the development and commercialization of clinical assets to address the unmet medical needs of patients. The Company¿s licensed clinical assets are focused on idiopathic male infertility and autoimmun... Conduit Pharmaceuticals, Inc. is a disease agnostic life science company. The Company is engaged in the development and commercialization of clinical assets to address the unmet medical needs of patients. The Company¿s licensed clinical assets are focused on idiopathic male infertility and autoimmune diseases or immunodeficient conditions like uveitis, preterm labor, renal transplant rejection and Hashimoto¿s Thyroiditis. The Company¿s asset pipeline includes AZD1656 (a Glucokinase Activator), and AZD5904 (a Myeloperoxidase Inhibitor). AZD1656 is a glucokinase activator used in diabetes mellitus. It is used as a treatment option for Hashimoto¿s Thyroiditis (HT) and Graves¿ disease, including investigating any negative side effects of the use of AZD1656 as compared with treatment options for Hashimoto¿s Thyroiditis and Graves¿ disease. AZD5904 includes a potent, irreversible inhibitor of human myeloperoxidase (MPO), that has the potential to treat Idiopathic Male Infertility (IMI). Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.conduitpharma.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Conduit Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CDT. The last closing price for Conduit Pharmaceuticals was $0.12. Over the last year, Conduit Pharmaceuticals shares have traded in a share price range of $ 0.095 to $ 7.7509.

Conduit Pharmaceuticals currently has 96,004,699 shares outstanding. The market capitalization of Conduit Pharmaceuticals is $11.17 million. Conduit Pharmaceuticals has a price to earnings ratio (PE ratio) of -267.04.

Ask ADVFN Intelligence (AI)

CDT Latest News

More News

Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

SAN DIEGO and LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), today announced it will be participating in the H.C. Wainwright...

August 28 2024
GlobeNewswire Inc.

Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders

Conduit Pharmaceuticals announces plans to initiate Phase 2a trials in both systemic lupus erythematosus and ANCA-associated vasculitis for its lead clinical candidate, AZD1656AZD1656, a HK-4...

August 12 2024
GlobeNewswire Inc.

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

Conduit Pharmaceuticals enters into exclusive license agreement with AstraZeneca for HK-4 Glucokinase activators AZD1656 and AZD5658 targeting autoimmune indications and myeloperoxidase inhibitor...

August 08 2024
GlobeNewswire Inc.

Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

SAN DIEGO and LONDON, July 16, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals" or "Conduit" or the “Company”) today announced the approval of a...

July 16 2024
GlobeNewswire Inc.

Conduit Pharmaceuticals to Join Russell 3000® Index

SAN DIEGO and LONDON, June 13, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (the “Company” or “Conduit"), today announced the Company is set to join the broad-market...

June 13 2024
GlobeNewswire Inc.

A Presidio Property Trust Major Investment To Be Part of Russell 2000®

SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Presidio Property Trust, Inc. (NASDAQ: SQFT; SQFTP; SQFTW) (“Presidio” or the “Company”), an internally managed, diversified real estate investment...

May 29 2024
GlobeNewswire Inc.

Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer

Conduit also appoints prominent intellectual property attorney Jeffrey Lindeman as a Consultant Leadership additions underscore Conduit’s commitment to strengthening and broadening its...

March 19 2024
GlobeNewswire Inc.

Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub

SAN DIEGO and LONDON, March 11, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals" or "Conduit") today announced the opening of cutting-edge...

March 11 2024
GlobeNewswire Inc.

Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

SAN DIEGO and LONDON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit"), a multi-asset, clinical-stage life science company delivering an efficient model...

January 31 2024
GlobeNewswire Inc.

Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference

SAN DIEGO and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit Pharmaceuticals” or “Conduit”), a multi-asset clinical-stage disease-agnostic life...

November 02 2023
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.00565.544554455450.1010.15740.0965564501280.11538748CS
4-0.0237-18.18879508830.13030.15740.095182307330.11335617CS
12-0.1254-54.05172413790.2320.4150.095172440020.14730435CS
26-2.9334-96.49342105263.043.50.09593008140.16821069CS
52-1.6334-93.87356321841.747.75090.09548052980.22965791CS
156-12.4934-99.15396825412.612.890.09545522870.24612183CS
260-12.4934-99.15396825412.612.890.09545522870.24612183CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TVGNTevogen Bio Holdings Inc
$ 1.18
(210.85%)
153.43M
VERBVerb Technology Company Inc
$ 13.4687
(70.27%)
21.49M
XPONExpion360 Inc
$ 3.64
(52.30%)
23.66M
LBPHLongboard Pharmaceuticals Inc
$ 58.79
(51.13%)
25.2M
RANIRani Therapeutics Holdings Inc
$ 2.771
(37.18%)
26.7M
MTEMMolecular Templates Inc
$ 0.3349
(-77.22%)
3M
ZPTAZapata Computing Holdings Inc
$ 0.0774
(-70.34%)
25.76M
SPPLSIMPPLE Ltd
$ 0.327
(-31.88%)
337.65k
VEVVicinity Motor Corporation
$ 0.081
(-30.83%)
3.44M
HUBCWHub Cyber Security Ltd
$ 0.0095
(-26.36%)
2.05k
TVGNTevogen Bio Holdings Inc
$ 1.18
(210.85%)
153.43M
NVDANVIDIA Corporation
$ 139.12
(3.20%)
90.03M
JTAIJet AI Inc
$ 0.1137
(12.57%)
72.15M
SQQQProShares UltraPro Short QQQ
$ 6.9901
(-2.51%)
50.52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 9.4788
(0.84%)
46.09M

CDT Discussion

View Posts
Poundthetable Poundthetable 1 month ago
CDT will just drift lower from here...
👍️0
everton44 everton44 1 month ago
BSFC great for the long term, just keep buying for now it 75 percent computer trading at 100 shares just to screw around with the pps all day.
👍️0
Poundthetable Poundthetable 1 month ago
that would be nice maybe i buy some today...
👍️0
everton44 everton44 1 month ago
moving huge, going to .20 by eow!!!!
👍️0
everton44 everton44 1 month ago
CDT go time
👍️0
Law of Averages Law of Averages 1 month ago
CDT on the move after hours almost .20
👍️0
glenn1919 glenn1919 2 months ago
CDT.....................................https://stockcharts.com/h-sc/ui?s=CDT&p=W&b=5&g=0&id=p86431144783
👍️0
RAlbert RAlbert 2 months ago
I am waiting too.
👍️0
DOGONE DOGONE 2 months ago
We move up this week.
👍️0
Awl416 Awl416 2 months ago
Oink oink
👍️0
Awl416 Awl416 2 months ago
Fall for it….
👍️0
Invest-in-America Invest-in-America 2 months ago
CDT: Very-well-stated, Colonel Trendzone, Sir!!! (And boy, did I myself get suckered!! And then, I finally read the proverbial 'fine print'!!! See live film-clip of ME, right now, below doing a 'Will Smith' upon my own stupid FACE!!!)

👍️0
trendzone trendzone 2 months ago
Another on their backs BS biotech that used head lines to pump their stock and turn it into the toxic cesspool it has been like forever, perhaps all those who have been waiting like forever to sell,all got out today, and perhaps this sleazeball company and stock can bounce from here,with today's total wash out of most of the sleazeballs responsible for the pump and dump gone.
👍️0
Invest-in-America Invest-in-America 2 months ago
CDT: Awful day --- and my APOLOGIES to all here again regarding my PUMPING this turd in the first place!!! (On much closer reading of their PR today, all that AstraZeneca did was DUMP their knowingly-hopeless DRUGS upon CDT to see if CDT might be able to make something out of such Pharma Snakeoil nonsense!!! I.e., if the CDT PR had been INVERTED --- in that AztraZeneca had contracted with CDT to continue work on CDT's drugs --- then the CDT stock itself surely would have soared to another GALAXY!!!)
👍️0
Awl416 Awl416 2 months ago
MURF had its fun a year ago. never end well
👍️0
Awl416 Awl416 2 months ago
Like I said just another failed SPAC. Good luck
👍️0
trendzone trendzone 2 months ago
Such a shame with the news they had to be such a bunch of filthy toxic slobs,with the low life insides probably tipping off insiders with large positions,and naked shorting hedge fund trash, to fill their greedy little pockets, perhaps all that filthy trash has sold out, and this piece of toxic trash can bounce off it's azz.
👍️0
gail gail 2 months ago
i got out earlier, before the full crash.
👍️0
Adam16 Adam16 2 months ago
All that wasted volume!!! GL
👍️0
DOGONE DOGONE 2 months ago
Everyone that bought and held today lost money. What a classic case of manipulation.!
👍️0
Me2Greedy Me2Greedy 2 months ago
Gap fill @.19 then run back up
👍️0
Invest-in-America Invest-in-America 2 months ago
CDT: THANKS, Gail --- what a MESS!!
👍️0
gail gail 2 months ago
i would never ever do………..

…


that and it was my dumb fault for going after a runner after news. i know they all dilute into news, but hey, i trust you and gave it a shot. i know you meant well.
👍️0
Invest-in-America Invest-in-America 2 months ago
CDT: You were very KIND & GRACIOUS for not divulging WHO that "PM" was from, Gail. Well, as you already know, it was from ME --- iHub's official IDIOT of the day, if not the YEAR. (And one last time, my APOLOGIES to you for this debacle.)
👍️0
RAlbert RAlbert 2 months ago
What is the reason for downfall from $3 to $.16? Anybideayit can go back to the past levels with this announcement?
👍️0
DOGONE DOGONE 2 months ago
Gail..I know the feeling...I do that a lot too. Slap myself a lot for not thinking.
👍️0
gail gail 2 months ago
yup, i got suckered in with….

…

a pm earlier. and then they got quiet. i will never learn.
👍️0
Adam16 Adam16 2 months ago
Yup good example here imo
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
BACK TO 16C THEN A RS IS NEEDED
👍️0
DOGONE DOGONE 2 months ago
My ave is .2523 June 1st this stock was 3.00.
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
HOWS THAT POSITIVITY WORKING OUT FOR YA...LOL
👍️0
gail gail 2 months ago
too much diluting into the news. next.
👍️0
Poundthetable Poundthetable 2 months ago
Im in here lets see if its got legs...
👍️0
MartinLutherKing MartinLutherKing 2 months ago
On the double take here RNAZ going for the tripple
👍️0
madras50 madras50 2 months ago
i know who that is and your comment makes no sense but good luck.
👍️0
gail gail 2 months ago
let’s do this!!!!
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
volume is there
👍️0
gail gail 2 months ago
i knew you couldnt resist! im in too!
👍️0
Awl416 Awl416 2 months ago
Nice move but many still dead in the water with this SPAC
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
in for a magnet at 59c
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
this is not a tony robbins seminar
👍️0
madras50 madras50 2 months ago
not saying i agree or disagree with you but you're a real Debbie Downer sometimes. Any chance I could see 2 or 3 that your long on?
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
how many shares is astra dumping on this deal.....As part of the License Agreement, AstraZeneca will be issued shares of common stock in Conduit
👍️0
Invest-in-America Invest-in-America 2 months ago
CDT: Deal with AstraZenega today --- how's its PRICE doing right now??? Who cares???
https://investorplace.com/2024/08/why-is-conduit-pharmaceuticals-cdt-stock-up-123-today/

👍️0
Invest-in-America Invest-in-America 2 months ago
CDT: Biggest runner-stunner of the YEAR!!! See ya-all up on Planet Jupiter!!!

👍️0
Viewmont Viewmont 2 months ago
$CDT $CDT Active pre-market.
Conduit Pharmaceuticals enters into exclusive license agreement with AstraZeneca for HK-4 Glucokinase activators AZD1656 and AZD5658 targeting autoimmune indications and myeloperoxidase inhibitor AZD5904 targeting idiopathic male infertility— Viewmont (@viewmont12) August 8, 2024
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
its amazing the internet clowns think all these diluted stocks are retail volume
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
another bio to rinse out the 16 million warrants..dirty ole spac
👍️0
Awl416 Awl416 2 months ago
Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments
👍️0
Awl416 Awl416 2 months ago
LOL
👍️0

Your Recent History

NASDAQ
CDT
Conduit Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved